XYL · Q2 2026 Earnings

Cautious

Xylem Inc.

Reported July 28, 2026

30-second summary

Xylem posted Q2 revenue of $2.34B (+1.5% YoY, +1% organic) with adjusted EPS of $1.46 — $0.10 above the high end of the Q1-issued guide — on adjusted EBITDA margin of 23.3%, 80–130bps above the prior guide band. Orders of $3.1B (+41% organic) drove book-to-bill to 1.32, but management simultaneously narrowed FY revenue to a $9.2B point (eliminating the $9.3B upside) and lowered FY organic growth to 2–3% from 2–4%, capping near-term top-line expectations even as they raised FY EPS by $0.20 to $5.55–$5.70. The gap between backlog build and revenue conversion is the story: margin engine is intact, but the growth engine has been deferred.

Headline numbers

EPS

Q2 FY2026

$1.46

+9.0% vs est.

Revenue

Q2 FY2026

$2.34B

+1.5% YoY

-0.2% vs est.

Gross margin

Q2 FY2026

41.2%

Free cash flow

Q2 FY2026

$0.22B

Operating margin

Q2 FY2026

16.7%

Key financials

Q2 FY2026

Metric	Q2 FY2026	Q2 FY2025	YoY	Q1 FY2026	QoQ
Revenue	$2.34B	$2.30B	+1.5%	$2.13B	+9.9%
EPS	$1.46	$1.26	+15.9%	$1.12	+30.4%
Gross margin	41.2%	38.8%	+240bps	37.8%	+340bps
Operating margin	16.7%	13.3%	+340bps	11.5%	+520bps
Free cash flow	$0.22B	$0.17B	+29.6%	$0.02B	+1116.7%

Guidance

Xylem raised FY2026 EPS guidance and EBITDA margin following a strong Q2 beat, but narrowed full-year revenue and organic growth guidance, signaling moderating underlying demand.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Revenue	Q2 FY2026	$2.29B to $2.35B	$2.336B	in-line	Met
EPS (non-GAAP)	Q2 FY2026	$1.31 to $1.36	$1.46	+$0.10 above high end	Beat
Adjusted EBITDA Margin	Q2 FY2026	22% to 22.5%	23.3%	+80 to +130 bps above range	Beat

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Revenue	FY2026	$9.2B to $9.3B	$9.2B	−$0.1B (−1.1% high end)	Lowered
EPS (non-GAAP)	FY2026	$5.35 to $5.60	$5.55 to $5.70	+$0.10 low end; +$0.10 high end	Raised
Adjusted EBITDA Margin	FY2026	22.9% to 23.3%	23.1% to 23.5%	+20 to +20 bps	Raised
Organic Revenue Growth	FY2026	2% to 4%	2% to 3%	−100 bps high end	Lowered

Reaffirmed unchanged this quarter: Free Cash Flow Margin (10.2% to 11.0%)

Segment KPIs

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Water Infrastructure	$0.683B	$0.65B	+5.1%
Applied Water	$0.501B	$0.483B	+3.7%
Measurement and Control Solutions	$0.508B	—	-5.9%
Water Solutions and Services	$0.644B	$0.628B	+2.5%

Other KPIs

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Orders	$3.1 billion	—	—
Orders Growth (Organic)	41%	—	—
Revenue Growth (Organic)	1%	—	—
Adjusted EBITDA Margin	23.3%	21.8%	—
Book-to-Bill Ratio	1.32	—	—
Net Income Margin	11.3%	9.8%	—

Management tone

Transcript not available for this quarter; tone analysis limited to press-release language shifts versus prior quarter commentary.

Language pivoted from "monitoring volatility" to "trends broadening opportunity set." Through Q1, prepared remarks framed the macro as uncertain and guidance as prudent. This quarter's press-release qualitative statements pivot to secular framing: "the demand drivers behind our business continue to strengthen," "water is becoming increasingly strategic for both utilities and industrial customers," and — the newest thread — "the growth of AI infrastructure is increasing the strategic importance of water across a broader industrial ecosystem." Management is reaching for the AI-adjacent narrative to justify a 2–3% organic guide against a 41% orders print, converting the growth deferral into a portfolio-positioning story.

Confidence language re-emerges after a quarter of defensive framing. Q1's tone was "resilient with a solid first quarter financial performance despite a dynamic external environment." This quarter's press release closes with "we believe Xylem is well positioned for long-term growth and profitability" — the return of forward-affirmative language absent last quarter. Consistent with the EPS raise, the tone shift signals management now feels comfortable committing to the upgraded earnings trajectory even as it caps the revenue trajectory.

AI-water introduced as a standalone demand driver. Q4 FY25 opened the "water-as-AI-infrastructure" theme; Q1 went quiet on it. This quarter it returns as an explicit statement in the qualitative guidance section. The reintroduction is not incidental — with organic growth capped at 3% and orders up 41%, management needs a narrative that reconciles the two, and AI-driven industrial water demand is the framing being deployed.

Answers to last quarter's watch list

Q2 organic growth of "roughly 1%" vs the H2 ramp required to hit FY 2–4% organic — Q2 organic landed at 1%, exactly as guided. But the FY 2–4% band was narrowed to 2–3%, meaning management chose to cap the upside rather than commit to an H2 ramp of ~5%+. The mathematical tension in the Q1 guide has been resolved by lowering the ceiling, not by underwriting acceleration.

Resolved negatively

EPS guide behavior — Management raised the FY EPS band by $0.20 at both ends to $5.55–$5.70, resolving the two-consecutive-reaffirmations concern. The $1.46 Q2 print ($0.10 above the high end of the quarterly guide) forced the raise, and the pattern now mirrors 2025's underpromise-then-raise cadence.

Resolved positively

MCS growth trajectory — On an organic basis, MCS decelerated from +1% in Q1 to -1% in Q2; reported growth swung from +4% to -5.9% as a divestiture began flowing through the comp. The segment is softening but not collapsing organically — the sharper reported decline overstates the underlying deceleration.

Continue monitoring

WSS organic growth ex the $850M contract — WSS revenue of $644M (+2.5% reported, +1% organic) improved modestly from Q1. The megacontract's in-year recognition is small enough that most of the sequential improvement is likely underlying, but the organic figure remains modest.

Continue monitoring

China sequential trajectory — Not called out with a specific figure in the disclosed data. With MCS organic still slightly negative, the China walkaway remains a plausible contributor, but sequential floor-formation was not directly disclosed on this print.

Continue monitoring

M&A deployment pace post-Q2 reassessment — No fresh transactions disclosed. The $1B annual target and post-Q2 reassessment cadence remain the framework.

Continue monitoring

What to watch into next quarter

Book-to-bill of 1.32 conversion into H2 revenue — a 1.32 book-to-bill on 41% organic order growth should mechanically drive H2 revenue acceleration; if Q3 organic remains at ~1% or deteriorates, the disconnect between backlog and revenue conversion becomes a structural execution question, not a phasing question

MCS organic trajectory — Q2 organic at -1% is a modest deterioration from Q1's +1%; a Q3 organic print further negative would confirm the segment is weakening structurally rather than absorbing a one-off divestiture drag

Whether the FY organic 2–3% guide holds or is cut further — if Q3 organic prints below 2%, arithmetic forces Q4 organic to ~4%+ to hit even the low end, testing whether the newly narrowed band is achievable

Implied Q3 FY26 setup vs Q3 FY25's $2.27B comp — if management guides Q3 FY26 organic below flat, the implied Q3 range would signal further FY guide risk

Adjusted EBITDA margin holding above 23% in H2 — the FY 23.1–23.5% band and Q2's 23.3% print imply H2 margins hold at or near this level; any Q3 print below 22.5% would suggest the raised FY EBITDA margin is at risk despite the EPS raise

AI-water narrative substantiation — management introduced AI infrastructure as a demand driver in the press release; watch for specific customer wins, order color, or segment-level AI-adjacent revenue disclosure on the Q3 print to validate whether this is a real demand vector or a positioning frame

Sources

Xylem Inc. Q2 FY2026 earnings press release (Form 8-K Exhibit 99.1), filed July 28, 2026 — https://www.sec.gov/Archives/edgar/data/1524472/000152447226000108/xyl07282026ex991.htm
Prior-quarter guidance baselines and watch-list items sourced from Tapebrief Q1 FY2026, Q4 FY2025, Q3 FY2025, and Q2 FY2025 briefs.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.